跳转至内容
Merck
所有图片(1)

文件

78013

Supelco

4-(甲基亚硝氨基)-1-(3-吡啶基)-1-丁酮

analytical standard

别名:

4-(甲基亚硝胺)-1-(3-吡啶基)-1-丁酮, NNK

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C10H13N3O2
CAS号:
64091-91-4
分子量:
207.23
MDL號碼:
MFCD00274580
分類程式碼代碼:
41116107
PubChem物質ID:
329768118
NACRES:
NA.24

等級

analytical standard

品質等級

100

化驗

≥98.0% (GC)

儲存期限

limited shelf life, expiry date on the label

技術

HPLC: suitable
gas chromatography (GC): suitable
solid phase extraction (SPE): suitable

應用

cleaning products
cosmetics
food and beverages
personal care

格式

neat

儲存溫度

2-8°C

SMILES 字串

CN(CCCC(=O)c1cccnc1)N=O

InChI

1S/C10H13N3O2/c1-13(12-15)7-3-5-10(14)9-4-2-6-11-8-9/h2,4,6,8H,3,5,7H2,1H3

InChI 密鑰

FLAQQSHRLBFIEZ-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

一般說明

用于 Supelco MIP SPE 滤筒的标准品。有关更多信息，请索取 Supelco 资料 T407075、T706031

應用

有关合适仪器技术的更多信息，请参考产品′s分析证书。如需进一步支持，请联系技术服务。

象形圖

Skull and crossbonesHealth hazard
GHS06,GHS08

訊號詞

Danger

危險聲明

H301,H317,H351

危險分類

Acute Tox. 3 Oral - Carc. 2 - Skin Sens. 1

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

個人防護裝備

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number
BCCL2650
BCCH8268
BCCH6680
BCCJ7667
BCCD8854

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Slide 1 of 6

1 of 6

苯并[a]芘-d12 98 atom % D

Sigma-Aldrich

451797

苯并[a]芘-d12

苯-d6 "100%", 99.96 atom % D

Sigma-Aldrich

175870

苯-d6

苯并[a]芘 ≥96% (HPLC)

Sigma-Aldrich

B1760

苯并[a]芘

苯并[a]芘 analytical standard, for environmental analysis

Supelco

48564

苯并[a]芘

苯 analytical standard

Supelco

12540

苯

(−)-尼古丁 ≥99% (GC), liquid

Sigma-Aldrich

N3876

(−)-尼古丁

Naofumi Kameyama et al.
American journal of respiratory cell and molecular biology, 59(2), 179-188 (2018-02-15)
Lung cancer and chronic obstructive pulmonary disease are leading causes of morbidity and mortality worldwide, and cigarette smoking is a main risk factor for both. The presence of emphysema, an irreversible lung disease, further raises the risk of lung cancer
Wiebke Schormann et al.
The Journal of cell biology, 219(3) (2020-01-23)
Confocal micrographs of EGFP fusion proteins localized at key cell organelles in murine and human cells were acquired for use as subcellular localization landmarks. For each of the respective 789,011 and 523,319 optically validated cell images, morphology and statistical features
Huawei Qiu et al.
mAbs, 11(7), 1266-1275 (2019-06-15)
Deamidation evaluation and mitigation is an important aspect of therapeutic antibody developability assessment. We investigated the structure and function of the Asn-Gly deamidation in a human anti-CD52 IgG1 antibody light chain complementarity-determining region 1, and risk mitigation through protein engineering.
Aymeric Monteillier et al.
Scientific reports, 8(1), 14257-14257 (2018-09-27)
Lung cancer is the most lethal cancer in the world. About 80% of lung cancer deaths are linked to tobacco use. As a complement to tobacco control, efficient chemoprevention strategies are needed to tackle lung cancer epidemic. Resveratrol is one
Harald Hundsberger et al.
BMC genomics, 18(1), 450-450 (2017-06-10)
Recombinant peptide chips could constitute a versatile complementation to state-of-the-art in situ (chemical on-chip) synthesis, particle-based printing, or pre-manufactured peptide spotting. Bottlenecks still impeding a routine implementation - from restricted peptide lengths, low diversity and low array densities to high
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门